Oren Shuster, CEO of IM Cannabis Corp. (CSE:IMCC), joined Barrington Miller in the podcast studio to share how the company's foundation has been built on the experience of growing pharma-grade cannabis since 2010 (3:21), their focus on applying EU GMP standards to meet growing demand in Europe (5:13), and the important lessons learned through trial and error over the years (8:12). Listen until the end to learn more about the distinct differences between the EU/Israeli market vis-à-vis North America and the opportunity presented by the German medical cannabis market. 

🔴 Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe

#alwaysinvested

STAY CONNECTED WITH THE CSE
=============================

📧 - NEWSLETTER: https://go.thecse.com/CSE-Mailing-List-Subscribe
🎧 - PODCAST: https://blog.thecse.com/cse-podcasts/
📸 - INSTAGRAM: https://www.instagram.com/canadianexchange/
🤝 - LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange
👥 - FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/
🐦 - X: https://x.com/CSE_News
📝 - BLOG: https://blog.thecse.com/
🖥 - WEBSITE: https://thecse.com/
📖 - MAGAZINE: https://issuu.com/thecse/docs

©2024 CNSX Markets Inc. All rights reserved.